- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05767242
Early Neurophysiological Markers of Language Impairments
February 3, 2025 updated by: IRCCS Eugenio Medea
Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk
The present project aims at identifying very early electrophysiological risk markers for language impairments.
The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments.
In this project, all the infants of the Medea BabyLab cohort are followed-up until school age.
Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chiara Cantiani, PhD
- Phone Number: +39031877924
- Email: chiara.cantiani@lanostrafamiglia.it
Study Locations
-
-
LC
-
Bosisio Parini, LC, Italy, 23842
- Recruiting
- Associazione La Nostra Famiglia - IRCCS Eugenio Medea
-
Contact:
- Chiara Cantiani, PhD
- Phone Number: +39031877924
- Email: chiara.cantiani@lanostrafamiglia.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 8 years (Child)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy infants with and without familial risk for language impairments
Description
Inclusion Criteria:
- Healthy infants aged <24 months
- Infants with and without familial risk for language impairments (infants are assigned to the group with familial risk if at least one first-degree relative had a certified (clinical) diagnosis of language impairment or learning disability
- Both parents are native-Italian speakers
Exclusion Criteria:
- Gestational age < 37 weeks and/or birth weight < 2500 grams
- APGAR scores at birth at 1' and 5' < 7
- Bayley Cognitive Score < 7
- Presence of certified diagnosis of intellectual deficiency, attention-deficit disorder, sensorial and neurological disorders, or autism within first-degree relative
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
MEDEA BabyLab Cohort
|
Investigation of early neural markers using electrophysiology at 6-12-24 months
Individual behavioral assessment at later ages (3, 4.5, 6, and 8 years)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expressive vocabulary at age 3 years
Time Frame: Age 3 years
|
Standardized score in the Language Development Survey (Rescorla, 1989; Rescorla et al., 2014).
Minimum=5; Maximum=95 (higher scores mean a better outcome).
|
Age 3 years
|
|
Phonological awareness at age 3 years
Time Frame: Age 3 years
|
Raw score in a syllabic blending task (created ad hoc).
Scores are percentages of accuracy (higher scores mean a better outcome).
|
Age 3 years
|
|
Syntactic comprehension at age 3 years
Time Frame: Age 3 years
|
Standardized scores in the syntactic comprehension subtests, taken from 'Test for language evaluation', Cianchetti e Fancello, 1997.
Z-scores are calculated (higher scores mean a better outcome).
|
Age 3 years
|
|
Lexical comprehension at age 3 years
Time Frame: Age 3 years
|
Raw score in the lexical comprehension subtest, taken from 'Battery for language evaluation in children 4-12 years', Marini et al., 2015.
Scores are percentages of accuracy (higher scores mean a better outcome).
|
Age 3 years
|
|
Short-term verbal memory at age 4.5 years
Time Frame: Age 4.5 years
|
Standardized scores in the pseudo-word repetition subtest, taken from 'Battery for language evaluation in children 4-12 years', Marini et al., 2015.
Z-scores are calculated (higher scores mean a better outcome).
|
Age 4.5 years
|
|
Phonological awareness at age 4.5 years
Time Frame: Age 4.5 years
|
Standardized scores in the phonological awareness subtests taken from 'Evaluation of phonological awareness skills', Marotta et al., 2008.
Mean=10, Standard Deviation=3 (higher scores mean a better outcome).
|
Age 4.5 years
|
|
Phonological awareness at age 6 years
Time Frame: Age 6 years
|
Composite score of the standardized scores in the phonological awareness subtests (phoneme identification, phonemic segmentation), Cornoldi et al., 2009.
Z-scores are calculated (higher scores mean a better outcome).
|
Age 6 years
|
|
Letter identification, knowledge, and writing at age 6 years
Time Frame: Age 6 years
|
Raw scores in the letter identification, knowledge, and writing subtests, taken from "Preschool Screening", Savelli et al., 2013.
Minimum=0, Maximum=20 (higher scores mean a better outcome).
|
Age 6 years
|
|
Reading (accuracy, speed and comprehension) at age 8 years
Time Frame: Age 8 years
|
Standardized scores in the reading subtest, taken from 'Reading and comprehension assessment', Bonifacci et al., 2014.
Z-scores are calculated (higher scores mean a better outcome).
|
Age 8 years
|
|
Spelling at age 8 years
Time Frame: Age 8 years
|
Standardized scores in the spelling task (Marinelli et al., 2016).
Z-scores are calculated (higher scores mean a better outcome).
|
Age 8 years
|
|
Phonemic awareness at age 8 years
Time Frame: Age 8 years
|
Raw scores in the spoonerisms subtest taken from 'Evaluation of phonological awareness skills', Marotta et al., 2008.
Minimum=0, Maximum=30 (higher scores mean a better outcome).
|
Age 8 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lexical access at age 4.5 years
Time Frame: Age 4.5 years
|
Standardized score in Rapid Automatic Naming.
Mean=10, Standard Deviation=3 (higher scores mean a better outcome).
|
Age 4.5 years
|
|
Naming and articulatory accuracy at age 3 years
Time Frame: Age 3 years
|
Raw scores in the test of naming and articulatory accuracy (created ad hoc).
Scores are percentages of accuracy (higher scores mean a better outcome).
|
Age 3 years
|
|
Nonverbal cognitive score at age 4.5 years
Time Frame: Age 4.5 years
|
Standardized score in the block design subtest, taken from 'Wechsler Preschool and Primary Scale of Intelligence, 3rd edition'.
Mean=10, Standard Deviation=3 (higher scores mean a better outcome).
|
Age 4.5 years
|
|
Lexical access at age 6 years
Time Frame: Age 6 years
|
Standardized score in Rapid Automatic Naming, taken from Urgesi et al., 2011.
Z-scores are calculated (higher scores mean a better outcome).
|
Age 6 years
|
|
Visual-motor integration at age 6 years
Time Frame: Age 6 years
|
Standardized score in the 'Developmental Test of Visual-Motor Integration', Preda, 2000.
Minimum=5; Maximum=95 (higher scores mean a better outcome).
|
Age 6 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
January 26, 2023
First Submitted That Met QC Criteria
March 1, 2023
First Posted (Actual)
March 14, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 3, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 918
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Learning Disabilities
-
Centre Hospitalier Intercommunal CreteilAssociation pour la recherche des troubles de l'apprentissage; Orthoédition; Association... and other collaboratorsCompletedDevelopmental Disability | Learning Disorders, SpecificFrance, Martinique
-
Hamad Medical CorporationNot yet recruiting
-
Massachusetts General HospitalTerminatedAutism Spectrum Disorder | Autism | Nonverbal Learning DisabilityUnited States
-
IRCCS Burlo GarofoloCompleted
-
Vanderbilt UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMath Learning DisabilityUnited States
-
Alanya Alaaddin Keykubat UniversityNot yet recruitingDental Caries | Oral Hygiene | Specific Learning DisabilitiesTurkey (Türkiye)
-
Dilara Ulger OzbekCompletedSpecific Learning Disability | Healthy (Controls)Turkey (Türkiye)
-
Mila (bMotion Technologies)CompletedDyslexia | Learning Disabilities | Learning Disorder, Specific | Specific Learning Disorder, With Impairment in ReadingFrance
-
Alanya Alaaddin Keykubat UniversityNot yet recruitingOral Hygiene | Dental Plaque | Specific Learning DisabilitiesTurkey (Türkiye)
-
Bezmialem Vakif UniversityCompletedSpecific Learning DisorderTurkey
Clinical Trials on Electrophysiological recording
-
Hadassah Medical OrganizationUnknownParkinson's DiseaseIsrael
-
Prof. Dr. Volker Arnd CoenenUniversity of FreiburgRecruiting
-
IRCCS Eugenio MedeaBasque Center on Cognition, Brain and Language (BCBL)RecruitingLanguage Development Disorders | Infant Development | Language Development | Infant Developmental AssessmentItaly
-
Hospices Civils de LyonCompleted
-
Centre Hospitalier St AnneRecruitingPathology Requiring Deep Brain Stimulation TherapyFrance
-
University of CalgaryRecruitingPhysiology | Cerebrovascular CirculationCanada
-
Luca ValciCompletedCerebral AneurysmSwitzerland
-
Assiut UniversityNot yet recruitingWolff-Parkinson-White Syndrome
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureIsrael, Belgium, Poland, United Kingdom
-
Maxima Medical CenterNot yet recruitingPregnancy | Monitoring